结构:Cn1c(CN2CCN(C(C)(C)C(N)=O)CC2)nc2c(N3CCOCC3)nc(Cl)nc21
HCID58439189

2-(4-((2-Chloro-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperazin-1-yl)-2-methylpropanamide

2-[4-[(2-chloro-9-methyl-6-morpholin-4-ylpurin-8-yl)methyl]piperazin-1-yl]-2-methylpropanamide

C19H29ClN8O2436.9 g/molCAS 1148003-36-4

IDENTITY

结构与身份

标准 SMILES
Cn1c(CN2CCN(C(C)(C)C(N)=O)CC2)nc2c(N3CCOCC3)nc(Cl)nc21
InChIKey
NWMQTKDAIGDTBE-UHFFFAOYSA-N
分子式
C19H29ClN8O2
平均分子量
436.9 g/mol
单同位素质量
436.2101999

COMPUTED

结构计算性质

已同步
XLogP
0.3
极性表面积
106 Ų
氢键供体
1
氢键受体
8
可旋转键
5
重原子
30
形式电荷
0
复杂度
611

ALIASES

名称与别名

8
SCHEMBL2398263NWMQTKDAIGDTBE-UHFFFAOYSA-NDTXSID8011168041148003-36-42-(4-((2-Chloro-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperazin-1-yl)-2-methylpropanamide2-(4-{[2-Chloro-9-methyl-6-(morpholin-4-yl)-9H-purin-8-yl]methyl}piperazin-1-yl)-2-methylpropanamide2-[4-(2-Chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-ylmethyl)-piperazin-1-yl]-isobutyramide4-[[2-Chloro-9-methyl-6-(4-morpholinyl)-9H-purin-8-yl]methyl]-I+/-,I+/--dimethyl-1-piperazineacetamide

REACTIONS

参与反应

5
HRID144412

Training data from https://doi.org/10.1039/C8SC04228D (9/10)

作为反应物
HRID 144412 方程式

Training data from https://doi.org/10.1039/C8SC04228D (9/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID665965

Training data from https://doi.org/10.1039/C8SC04228D (3/10)

作为反应物
HRID 665965 方程式

Training data from https://doi.org/10.1039/C8SC04228D (3/10) · 10.1039/C8SC04228D

查看条件与参与物